Soligenix (SNGX) Total Debt (2020 - 2024)
Soligenix's (SNGX) quarterly Total Debt came in at $1.4 million in Q4 2024, down 57.9% YoY from $3.3 million in Q1 2024, and down 33.33% on a QoQ basis from $2.1 million in Q3 2024.
Soligenix (SNGX) Total Debt (2020 - 2024) Analysis & Trends
Soligenix (SNGX) has 5 years of Total Debt data on file, last reported at $1.4 million in Q4 2024.
- Quarterly Total Debt fell 57.9% year-over-year to $1.4 million in Q4 2024, while the trailing twelve-month figure through Dec 2024 was $1.4 million (down 57.9% YoY) and the FY2024 annual result came in at $1.4 million, down 57.9% from the prior year.
- Total Debt slipped to $1.4 million in Q4 2024, from $2.1 million in the prior quarter.
- In the past five years, Total Debt ranged from a high of $9.9 million in Q4 2022 to a low of $23213.0 in Q1 2021.
- A 5-year average of $2.6 million and a median of $2.7 million in 2024 frame the typical range for Total Debt.
- The widest YoY moves for Total Debt: up 42.2% in 2023, down 67.05% in 2023.
- Tracing SNGX's Total Debt over 5 years: stood at $92851.0 in 2020, then slumped by 75.0% to $23213.0 in 2021, then jumped by 42538.57% to $9.9 million in 2022, then tumbled by 67.05% to $3.3 million in 2023, then sank by 57.9% to $1.4 million in 2024.
- The last three Total Debt figures came in at $1.4 million (Q4 2024), $2.1 million (Q3 2024), and $2.7 million (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.52 Bn | 132.67 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.54 Bn | 78.55 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.31 Bn | 60.13 Bn | 1.37 Bn | - |
| 4 | Moderna | 61.77 Bn | 56.64 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.26 Bn | 37.16 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.19 Bn | 27.88 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.71 Bn | 10.31 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.52 Bn | - | 9.34 Bn |
| 10 | Soligenix | 6.06 Mn | 6.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1.37 Mn |
| Sep 30, 2024 | 2.06 Mn |
| Jun 30, 2024 | 2.75 Mn |
| Mar 31, 2024 | 3.00 Mn |
| Dec 31, 2023 | 3.26 Mn |
| Sep 30, 2023 | 2.92 Mn |
| Jun 30, 2023 | 2.84 Mn |
| Mar 31, 2023 | 6.00 Mn |
| Dec 31, 2022 | 9.90 Mn |
| Sep 30, 2022 | 3.00 Mn |
| Jun 30, 2022 | 2.00 Mn |
| Mar 31, 2021 | 23,213.00 |
| Dec 31, 2020 | 92,851.00 |
| Sep 30, 2020 | 162,489.00 |
| Jun 30, 2020 | 232,128.00 |